As per provisional Quantum Index numbers (QIM) of the Large Scale Manufacturing Industries, the LSMI output decreased by 5.49 percent for November 2022
Physician-administered macular degeneration drug Eylea sales were hurt during the height of the pandemic last year as patients were reluctant to visit doctors' offices.
Sales from eczema drug Dupixent, which are recorded by Regeneron partner Sanofi, were $1.17 billion, compared to $751.5 million a year earlier.
Pakistan plans on starting mass-production of snakebites anti-venom and a rabies vaccine next year to end its reliance on imports from India.
Dow University of Health Sciences' biotechnological facility will be able to produce 700,000 vials of venom antiserum annually to overcome the supply shortages in the country.